Navigation Links
Neurological Wellness Center Physicians Group Asks CBS to Air the 60-Minute Show “A New Shot at Life” in the United States
Date:4/10/2013

ellness Center, a private medical group in Managua Nicaragua, authorized this press release.

Presently all FDA-approved drugs for the treatment of Alzheimer’s disease simply slow the rate of disease progression. Enbrel, when administered to the area between cervical vertebrae C-5 and C-6, enables the recovery of cognitive function, reversing impairments to memory, resulting in an improved sense of well-being and more engaging social interaction. A portion of those people treated with perispinal Enbrel injections will go on to live normal lives and eventually die of causes unrelated to Alzheimer’s disease.

This 60 Minute episode clearly illustrates that rapid recovery of memory and cognitive functions is possible following a single perispinal injection of the drug Enbrel. There is a growing body of evidence that the impairments persons with Alzheimer’s disease experience are the result of the neuro-inflammatory response to the buildup of amyloid-beta plaques and tau proteins in the brain. TNF-alpha, a protein cytokine, is a central regulator of the human inflammatory response not only in the brain but throughout the body.

Excess TNF-alpha in the brain can disrupt synaptic communication. Excess TNF-alpha triggers a cycle whereby toxic amyloid-beta is produced. This results in greater levels of pro-inflammatory TNF-alpha. Etanercept (Enbrel) is a fusion of two proteins naturally occurring in the human body that was developed to treat various inflammatory diseases by binding to TNF-alpha, effectively neutralizing its ability to act on cell membranes. Enbrel treatment has a rapid effect, reversing cognitive impairment, and validating the role excess TNF-alpha has in the Alzheimer’s disease process. Enbrel’s long half-life (70 to 132 hours) enables a series of treatments to produce sequential progressive improvements in cognitive function that can be maintained long term. The standard method for delivering CNS-active medication to the b
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Ivy Neurological Sciences Internship program funded at TGen
2. Kids With Neurological Conditions at Higher Risk of Flu Death: CDC
3. New national clinical trials network for neurological disorders to foster cutting-edge treatments
4. The hidden disorder: Unique treatment proposed for childrens neurological disorder
5. Cedars-Sinai physician-scientist awarded $3M to study most common inherited neurological disorder
6. University Hospitals Neurological Institute to present 6th International 2013 Epilepsy Colloquium
7. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
8. Neurological Wellness Center Pays Tribute to Newly Released Study Announcing TBI Treatment Breakthrough
9. Neurological Wellness Center Posts 700% Sales Increase in 2012; Enters Strategic Alliance with Enbrel Buyer's Club to Provide Low Cost Enbrel
10. NIH clinical trial begins for treatment of rare, fatal neurological disorder
11. New technology may help doctors monitor concussions, aging, and neurological function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... 29, 2015 , ... Rio Salado College joined nine educational institutions ... part of the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded ... Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, which is designed to ...
(Date:8/28/2015)... ... 28, 2015 , ... The Kentucky State Department of Workforce Investment Commissioner Beth ... are applying for, they are unable to pass the initial drug test and therefore ... policies in order to be able to hire long-term, skilled talent. (1) Will Wesch, ...
(Date:8/28/2015)... Falls Church, VA (PRWEB) , ... ... ... and Cybersecurity Risk Management for Medical Devices:, Understanding the FDA’s Position and ... – Rockville, MD, http://www.fdanews.com/cybersecuritymd , This workshop, chaired by internationally ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... who might personally be struggling with chemical dependency, may be able to find ... Rehabilitation, a results-driven holistic treatment center for addiction located in Western Michigan. Focusing ...
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs and alcohol ... Strawbridge, gives a new approach on solutions in his new book ":Unraveling The ... and employees getting together for meaningful group meetings. "This would educate the employees ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3
... Data Can Be Integrated with Other Sales & ... Key Performance Indicators, Dynamic Graphs, And Custom Metrics ... leader in pharmaceutical data analysis and reporting solutions, ... within InView, the company,s graphical interactive portal for ...
... April 29 New analyses of data from ... beta-1b), sponsored by Bayer HealthCare Pharmaceuticals, were presented ... Annual Meeting. The study results showed that ... participants with multiple sclerosis (MS) were more likely ...
... warns more deaths are likely , , WEDNESDAY, April 29 ... become the first U.S. fatality in the spreading swine ... Dr. Richard Besser, acting director of the U.S. Centers ... other details on the case were immediately available, according ...
... Diluted Earnings per Share were $0.89, , Consistent ... Excluding Certain Significant Items, Increased 1% to $0.95- Worldwide ... , Increased 2%, Excluding the Impact of Foreign Exchange ... , Exchange, was Driven by Increases of 23% ...
... vs. $25.2 million - Increase of 34%Record Quarterly Diluted EPS: $0.17 vs. ... OWINGS MILLS, Md., April 29 Medifast, Inc. (NYSE: MED ... 31, 2009. First Quarter highlights included: , , ... quarter revenues increased 34% compared to 2008 to $33.7 million; , ...
... consider healthy hearing for spring 2009 , ... Stäfa, ... spring marks an opportunity for Americans to refresh and revitalize themselves. ... global initiative to inform and educate the public about the importance ...
Cached Medicine News:Health News:Archi-Tech InView Now Supports Managed Care Data, Offering an Interactive Dashboard for On-Demand Sales Planning and Reporting 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 2Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 3Health News:New Analyses from 16-Year Follow-up Trial with Betaseron(R) Demonstrated that Early and Sustained Treatment of Multiple Sclerosis Patients Enrolled in the Trial Affected Their Long-term Outcomes 4Health News:U.S. Reports First Swine Flu Death 2Health News:U.S. Reports First Swine Flu Death 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 2Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 3Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 4Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 5Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 6Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 7Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 8Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 9Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 10Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 11Health News:Wyeth Reports Earnings Results for the 2009 First Quarter 12Health News:Medifast Reports Record First Quarter 2009 Financial Results 2Health News:Medifast Reports Record First Quarter 2009 Financial Results 3Health News:Medifast Reports Record First Quarter 2009 Financial Results 4Health News:Medifast Reports Record First Quarter 2009 Financial Results 5Health News:Medifast Reports Record First Quarter 2009 Financial Results 6Health News:Medifast Reports Record First Quarter 2009 Financial Results 7Health News:Medifast Reports Record First Quarter 2009 Financial Results 8Health News:Medifast Reports Record First Quarter 2009 Financial Results 9Health News:This Spring, Hear the World 2Health News:This Spring, Hear the World 3
(Date:8/28/2015)... -- Perrigo Company plc ("Perrigo") (NYSE: PRGO ; TASE) ... leading OTC brands from GSK in an all cash ... clear demonstration of Perrigo,s unique ability to maximize brand ... 36 countries.  Perrigo Chairman, President and ... excited to complete this transaction, which clearly demonstrates our ...
(Date:8/28/2015)... -- The report "Eubiotics Market by Type (Probiotics, Prebiotics, Organic ... & by Region ( North America , ... Rest of the World) - Global Trends and Forecast to ... valued at USD 4.62 Billion in 2014 and is projected ... of 7.4% from 2015 to 2020. Browse ...
(Date:8/27/2015)... , Aug. 27, 2015  The Academy of ... and Drug Administration,s (FDA,s) draft guidance and proposed ... and biosimilars, to bear a nonproprietary name with ... been seeking a decision from the FDA on ... health care stakeholders urging the agency to use ...
Breaking Medicine Technology:Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4Eubiotics Market Worth 7.05 Billion USD by 2020 2Eubiotics Market Worth 7.05 Billion USD by 2020 3Eubiotics Market Worth 7.05 Billion USD by 2020 4Eubiotics Market Worth 7.05 Billion USD by 2020 5AMCP Is Disappointed in FDA's Draft Guidance and Proposed Rule Calling for Suffix on Nonproprietary Names of Biological Products 2
... workstations is designed for laboratories with limited ... automation platform for routine sample preparation and ... throughput, process consistency and safety. Windows ... you to control the robotic and liquid ...
... The Labcyte miniGene LD is a ... to 96-, 384- and 1536-well microplates. This ... 16 channel standard or wide orifice nozzle ... movement allow for accurate dispensing to a ...
... The QFill2 is the ideal system for fast, ... The pressure driven, pinch valve controlled dispensing mechanism, ... Whilst all of the components that come into ... dismantle, clean, and autoclave. The unique compact design ...
... an innovative reagent dispenser for plate ... fulfill the need for precise automated ... more, FlexDrop provides an efficient solution ... tedious task of plate preparation for ...
Medicine Products: